<DOC>
	<DOCNO>NCT00638456</DOCNO>
	<brief_summary>This study design evaluate whether oral viscous budesonide effective treat child Eosinophilic Esophagitis .</brief_summary>
	<brief_title>Use Topical Budesonide Treatment Eosinophilic Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Histologic evidence EE define great 20 eosinophil per hpf esophageal biopsy Ages 1 yr old Ability continue diet patient time EGD biopsy Adverse reaction allergy budesonide Pregnancy Chronic diseases require immunomodulatory therapy Use swallow topical corticosteroid EE within past 3 month Use systemic steroid 2 month prior study entry Upper gastrointestinal bleed within 4 month study entry Chronic use medication predispose upper gastrointestinal bleeding include nonsteroidal antiinflammatory medication anticoagulant Evidence adrenal suppression prior study entry Evidence concurrent eosinophilic gastritis , enteritis , colitis , proctitis Recent change asthma allergic rhinitis therapy 3 month</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Eosinophils</keyword>
	<keyword>Esophagitis</keyword>
	<keyword>Microscopy</keyword>
</DOC>